Facts
- Sectors
- Biotech, Biologics, Biomaterials
- Stage
- Seed
- Founders
- Maëva Coste, Jen Laws
Is this your organization? Claim it
BioWraptor Raises $1.5M Pre-Seed to Commercialize Room-Temperature Biomolecule Stabilization Technology
BioWraptor raised $1.5 million in a pre-seed round to advance its room-temperature biomolecule stabilization technology, aiming to reduce refrigeration needs for research tools, diagnostics, medicines and other products. The New York startup, founded by Maëva Coste and Jen Laws, will use the funds to expand labs, support customer pilots, and push toward commercialization while exploring applications in agriculture, cosmetics and space.
BioWraptor raises $1.5M pre-seed to commercialize tardigrade-inspired room-temperature biomolecule stabilizer
BioWraptor closed a $1.5M pre-seed to commercialize a tardigrade-inspired, naturally derived “wrap” that stabilizes fragile biomolecules at room temperature to reduce reliance on cold-chain logistics and expand access to medicines and diagnostics.
BioWraptor Raises $1.5M Pre-Seed to Commercialize Tardigrade-Inspired Room-Temperature Stabilization for Biologics
BioWraptor raised $1.5 million in a pre-seed round to advance its room-temperature stabilization technology for fragile biomolecules—using naturally derived building blocks inspired by tardigrades—to reduce cold-chain dependence and expand access to biologics and other biotech applications.
See all 5 stories, episodes and videos about BioWraptor.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events